Curi Bio
Human Data for Next Generation Medicines
Seattle, United States
59 employees
Grant
Total: $20.40M
AI, Biopharma +1
General Information
Seattle, United States
BounceWatch is an independent company data service, not affiliated with Curi Bio. To contact Curi Bio, visit curibio.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Curi Bio compare?
A PDF of Curi Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Curi Bio soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Curi Bio on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
About Curi Bio
Business keywords: 3D tissue models, biosystems, AI/ML-enabled insights, drug safety, efficacy, potency, tissue engineering, stem cell biology, mechanobiology, drug screening, drug development, high-throughput screening, iPSC-CM, disease modeling
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | $4.40M | 1 |
National Institutes of Health
|
23 Aug 2023 |
| Series A | $10.00M | 3 |
|
29 Dec 2021 |
| Series A | $6.00M | 1 |
|
18 Mar 2021 |
Curi Bio Alternatives & Competitors
View All Alternatives
Generate human-specific efficacy and safety data with PhysioMimix® microphysiological systems.
Capture the Untapped Value of Therapeutics
FAQ About Curi Bio
Source: BounceWatch company record for Curi Bio, https://bouncewatch.com/company/curi-bio, updated 9 June 2026. When citing, please name BounceWatch and link this page.
